- Home
- TLSI vs ATLN Comparison
TLSI vs ATLN Comparison
Compare TLSI & ATLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ATLN
- Stock Information
- Founded
- TLSI 2010
- ATLN 2014
- Country
- TLSI United States
- ATLN United States
- Employees
- TLSI N/A
- ATLN N/A
- Industry
- TLSI Medical Specialities
- ATLN
- Sector
- TLSI Health Care
- ATLN
- Exchange
- TLSI Nasdaq
- ATLN NYSE
- Market Cap
- TLSI 158.0M
- ATLN 186.7M
- IPO Year
- TLSI N/A
- ATLN 2021
- Fundamental
- Price
- TLSI $5.77
- ATLN $2.50
- Analyst Decision
- TLSI Strong Buy
- ATLN
- Analyst Count
- TLSI 6
- ATLN 0
- Target Price
- TLSI $11.75
- ATLN N/A
- AVG Volume (30 Days)
- TLSI 40.4K
- ATLN 20.3K
- Earning Date
- TLSI 03-27-2025
- ATLN 01-01-0001
- Dividend Yield
- TLSI N/A
- ATLN N/A
- EPS Growth
- TLSI N/A
- ATLN N/A
- EPS
- TLSI N/A
- ATLN N/A
- Revenue
- TLSI $26,891,000.00
- ATLN $429,260,149.00
- Revenue This Year
- TLSI $61.29
- ATLN N/A
- Revenue Next Year
- TLSI $53.21
- ATLN N/A
- P/E Ratio
- TLSI N/A
- ATLN N/A
- Revenue Growth
- TLSI 67.90
- ATLN 5.50
- 52 Week Low
- TLSI $3.50
- ATLN $1.30
- 52 Week High
- TLSI $10.42
- ATLN $8.98
- Technical
- Relative Strength Index (RSI)
- TLSI 68.94
- ATLN N/A
- Support Level
- TLSI $5.40
- ATLN N/A
- Resistance Level
- TLSI $5.82
- ATLN N/A
- Average True Range (ATR)
- TLSI 0.24
- ATLN 0.00
- MACD
- TLSI 0.01
- ATLN 0.00
- Stochastic Oscillator
- TLSI 89.19
- ATLN 0.00
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.